WO2002002516A3 - Inhibitors of hiv integrase - Google Patents

Inhibitors of hiv integrase Download PDF

Info

Publication number
WO2002002516A3
WO2002002516A3 PCT/US2001/019923 US0119923W WO0202516A3 WO 2002002516 A3 WO2002002516 A3 WO 2002002516A3 US 0119923 W US0119923 W US 0119923W WO 0202516 A3 WO0202516 A3 WO 0202516A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
inhibitors
integrase
present invention
hiv integrase
effective
Prior art date
Application number
PCT/US2001/019923
Other languages
French (fr)
Other versions
WO2002002516A2 (en )
Inventor
Robert W Harrison
Anna Marie Skalka
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34Amino anthraquinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen, hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Abstract

The present invention is a series of novel and effective inhibitors of integrase, an essential in the life cycle of retroviruses. These compounds were designed to have a restricted conformation for the determination of the integrase binding site and mechanism of inhibition. The integrase inhibitors of the present invention are effective in the submicromolar range, and thereby provide novel lead compounds for the development of anti-viral therapeutics.
PCT/US2001/019923 2000-06-30 2001-06-22 Inhibitors of hiv integrase WO2002002516A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US21547400 true 2000-06-30 2000-06-30
US60/215,474 2000-06-30

Publications (2)

Publication Number Publication Date
WO2002002516A2 true WO2002002516A2 (en) 2002-01-10
WO2002002516A3 true true WO2002002516A3 (en) 2002-10-24

Family

ID=22803123

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019923 WO2002002516A3 (en) 2000-06-30 2001-06-22 Inhibitors of hiv integrase

Country Status (1)

Country Link
WO (1) WO2002002516A3 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504053A (en) * 2001-08-31 2005-02-10 ニューロケム (インターナショナル) リミテッド Amidine derivatives for the amyloidosis treatment
EP1558611B1 (en) * 2002-10-31 2010-01-06 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
US7262223B2 (en) 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CA2563761C (en) 2004-04-26 2009-12-29 Pfizer Inc. Inhibitors of the hiv integrase enzyme
JP2007534739A (en) 2004-04-26 2007-11-29 ファイザー・インク Its use as pyrrolopyridine derivatives and hiv integrase inhibitors
US8008312B2 (en) 2005-01-07 2011-08-30 Emory University CXCR4 antagonists for the treatment of HIV infection
KR20070115879A (en) * 2005-01-07 2007-12-06 에모리 유니버시티 Cxcr4 antagonists for the treatment of medical disorders
EP2041067A4 (en) * 2006-07-11 2009-11-25 Univ Emory Cxer4 antagonists including diazine and triazine structures for the treatment of medical disorders
WO2011007038A3 (en) * 2009-07-15 2011-03-10 Universidade De Santiago De Compostela Use of compounds derived from bis-benzamidines as fluorogenic agents for signalling specific sequencecs of double-strand dna, and novel compounds
ES2351652B1 (en) * 2009-07-15 2011-12-05 Universidade De Santiago De Compostela Use of compounds derived from bis-benzamidios as fluorogenic agents for signaling specific DNA sequences double-stranded.
ES2355031B2 (en) * 2009-07-15 2011-12-26 Universidade De Santiago De Compostela Bis-benzamidinios derivatives and their use as recognition sequences of DNA.
ES2368276B2 (en) * 2010-04-27 2012-06-28 Universidad De Santiago De Compostela bis-derivatives as fluorogenic agents benzamidinios specific signal sequences dsDNA.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1931122A1 (en) * 1968-06-20 1970-02-12 Fuji Photo Film Co Ltd Color developer composition and process for color reversal development of a photographic multicolor multilayer element
EP0672727A2 (en) * 1994-03-14 1995-09-20 Ciba-Geigy Ag Anthraquinone dyes, process for their preparation and the use thereof
WO1998038170A1 (en) * 1997-02-28 1998-09-03 The University Of North Carolina At Chapel Hill Substituted benzimidazoles and their use for treating retroviral infection
WO1998050347A1 (en) * 1997-05-05 1998-11-12 The Regents Of The University Of California Naphthols useful in antiviral methods
WO1999025327A2 (en) * 1997-11-14 1999-05-27 Warner-Lambert Company Small molecule intervention in hiv-1 replication
WO1999048371A1 (en) * 1998-03-27 1999-09-30 The Regents Of The University Of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1931122A1 (en) * 1968-06-20 1970-02-12 Fuji Photo Film Co Ltd Color developer composition and process for color reversal development of a photographic multicolor multilayer element
EP0672727A2 (en) * 1994-03-14 1995-09-20 Ciba-Geigy Ag Anthraquinone dyes, process for their preparation and the use thereof
WO1998038170A1 (en) * 1997-02-28 1998-09-03 The University Of North Carolina At Chapel Hill Substituted benzimidazoles and their use for treating retroviral infection
WO1998050347A1 (en) * 1997-05-05 1998-11-12 The Regents Of The University Of California Naphthols useful in antiviral methods
WO1999025327A2 (en) * 1997-11-14 1999-05-27 Warner-Lambert Company Small molecule intervention in hiv-1 replication
WO1999048371A1 (en) * 1998-03-27 1999-09-30 The Regents Of The University Of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HE ZHAO ET AL., J. MED. CHEM., vol. 40, 1997, pages 1186 - 1194, XP000926749 *
HE ZHAO ET AL: "COUMARIN BASED INHIBITORS OF HIV INTEGRASE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 40, no. 2, 1997, pages 242 - 249, XP002092069, ISSN: 0022-2623 *
KING, P. J. ET AL: "STRUCTURE-ACTIVITY RELATIONSHIPS: ANALOGUES OF THE DICAFFEOYLQUINICAND DICAFFEOYLTARTARIC ACIDS AS POTEN INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE AND REPLICATION", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 42, no. 3, 1999, pages 497 - 509, XP000919203, ISSN: 0022-2623 *

Also Published As

Publication number Publication date Type
WO2002002516A2 (en) 2002-01-10 application

Similar Documents

Publication Publication Date Title
WO2003068750A1 (en) Jnk inhibitor
JPS5653659A (en) Blood platelet coagulation suppressing agent
CA2505389A1 (en) Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
WO2003016254A1 (en) Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
CA2418656A1 (en) Proline derivatives and use thereof as drugs
WO2003059907A1 (en) Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
CA2508226A1 (en) Novel heterocyclic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
WO2003024941A1 (en) Naphthalene compounds and use thereof as drugs
JPS5414967A (en) Novel disazo compound and its preparation
WO2002070491A1 (en) Nitrogenous heteroaromatic ring derivative having hiv integrase inhibitory activity
JPS5721401A (en) Photopolymerizable composition
WO2003004497A1 (en) Novel heterocyclic compound
CA2532804A1 (en) Substituted 2-aminotetralin for the treatment of depression
JPS6133128A (en) Drug composition
WO2002080918A1 (en) Remedial or prophylactic agent for frequent urination or urinary incontinence
CA2406392A1 (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
WO2003024965A3 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
WO2002051837A3 (en) Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
JPH03193746A (en) Substituted alkylamine derivative
WO2001068633A1 (en) 2-phenylpyran-4-one derivatives
WO2003016279A1 (en) Fused-polycyclic compounds
CA2372912A1 (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
WO2003082837A1 (en) Hydroxymorpholinone derivative and medicinal use thereof
JPS5435837A (en) Crevice corrosion inhibitor

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP